Hyderabad: On the first day of the World Economic Forum (WEF) Summit in Davos, Switzerland, many companies have come forward to invest in Telangana with Lulu Group announcing to invest Rs 500 crore while Spain's Chemo Pharma announced to invest Rs 100 crore in their Hyderabad site expansion over next two years.
Telangana IT and Industries Minister KT Rama Rao, who is leading the Telangana delegation to WEF- 2022, held a series of meetings with various industry leaders at the Telangana pavilion and many companies have come forward to invest in Telangana after their meetings with the Minister, an official release said here on Monday.
Lulu Group would start their operations in the food processing sector in Telangana with a investment of Rs 500 crore, it said. The investment was announced during a meeting between Rama Rao, popularly known as KTR, and the company head Yusuf Ali in Davos. On behalf of the Telangana government, KTR handed over the necessary permission documents to Yusuf Ali for the food processing unit to be set up by the company.
Yusuf Ali said that besides this investment, they also have plans of setting up another unit in the food processing sector and an official announcement in this regard would be made soon. He said they would be laying the foundation stone for their food processing units shortly. The company's unit would export food processing products from Telangana, it said. Yusuf Ali further said the Lulu group would invest more in the construction of large-scale commercial complexes in the State of Telangana.
Expressing happiness over Lulu Group's investment decision, KTR said the Telangana government was working towards establishing demand for agricultural products and agricultural allied products through food processing units. Lulu Group's setting up an international-level food processing unit would help this cause, he said.
Chemo Pharma announced investment of Rs 100 crore in creation of second line in their production area in Hyderabad for the production of pharmaceutical finished dosage forms. The company is also planning to initiate a new active pharmaceutical ingredient and R&D centre in Hyderabad, along with continuing new product development activities in solids and injectable in Genome Valley here, the release said.
The announcement was made after Rama Rao's meeting with leadership of Chemo Group- Jean Daniel Bonny, R&D Director - Pharmaceuticals Generics Business at World Economic Forum, Davos.